Related references
Note: Only part of the references are listed.Dihydromyricetin attenuates hypertrophic scar formation by targeting activin receptor-like kinase 5
Xiaolu Ye et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
SPHK-2 Promotes the Particle-Induced Inflammation of RAW264.7 by Maintaining Consistent Expression of TNF-α and IL-6
Guangpu Yang et al.
INFLAMMATION (2018)
Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans
Judilyn Fuentes-Duculan et al.
EXPERIMENTAL DERMATOLOGY (2017)
Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing
Mark Hesketh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Arteriogenesis in murine adipose tissue is contingent on CD68+/CD206+ macrophages
Scott A. Seaman et al.
MICROCIRCULATION (2017)
Regulation of M1-type and M2-type macrophage polarization in RAW264.7 cells by Galectin-9
Ran Lv et al.
MOLECULAR MEDICINE REPORTS (2017)
Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway
Chuan Qin et al.
STROKE (2017)
High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1
Man K. S. Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages
Cheng Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Enforced Expression of Hoxa3 Inhibits Classical and Promotes Alternative Activation of Macrophages In Vitro and In Vivo
Hadeel Al Sadoun et al.
JOURNAL OF IMMUNOLOGY (2016)
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
Masayo Aoki et al.
MEDIATORS OF INFLAMMATION (2016)
Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation
Theodore S. Kapellos et al.
MEDIATORS OF INFLAMMATION (2016)
Keloids and Hypertrophic Scars Can Now Be Cured Completely: Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most Promising Current Therapeutic Strategy
Rei Ogawa et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2016)
Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection
Irina V. Tiper et al.
PATHOGENS AND DISEASE (2016)
AGEs Induced Autophagy Impairs Cutaneous Wound Healing via Stimulating Macrophage Polarization to M1 in Diabetes
Yuanyuan Guo et al.
SCIENTIFIC REPORTS (2016)
Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice
Clement Oyeniran et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Richard L. Proia et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
Yasuhiro Maeda et al.
JOURNAL OF IMMUNOLOGY (2015)
12-hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor
Min Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
siRNA Knockdown of Tissue Inhibitor of Metalloproteinase-1 in Keloid Fibroblasts Leads to Degradation of Collagen Type I
Masayo Aoki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway
Achilles Ntranos et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory
Nitai C. Hait et al.
NATURE NEUROSCIENCE (2014)
Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages
Yanqiu Geng et al.
STEM CELL RESEARCH & THERAPY (2014)
Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis
Anthony O. Awojoodu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis
Wei-Ching Huang et al.
BIOMOLECULES (2013)
Keloids and Hypertrophic Scars: Update and Future Directions
Chenyu Huang et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2013)
Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis
Masayuki Nagahashi et al.
CANCER RESEARCH (2012)
Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling
Victor W. Wong et al.
NATURE MEDICINE (2012)
Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis
Petra Keul et al.
CIRCULATION RESEARCH (2011)
The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720
Yu Hisano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
Trina A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2011)
Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite
Cherilyn R. Strader et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
Gerd G. Gauglitz et al.
MOLECULAR MEDICINE (2011)
Outcomes of Surgical Excision with Pressure Therapy Using Magnets and Identification of Risk Factors for Recurrent Keloids
Tae Hwan Park et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice
Tamaki Sumi et al.
CELL BIOLOGY INTERNATIONAL (2009)
Topical Application of Sphingosine-1-Phosphate and FTY720 Attenuate Allergic Contact Dermatitis Reaction through Inhibition of Dendritic Cell Migration
Ilka Reines et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Intralesional Botulinum Toxin Type A Injection as a New Treatment Measure for Keloids
Xiao Zhibo et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2009)
The relationship between keloid growth pattern and stretching tension - Visual analysis using the finite element method
Satoshi Akaishi et al.
ANNALS OF PLASTIC SURGERY (2008)
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis
Shahram Aarabi et al.
FASEB JOURNAL (2007)
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubipuitinylation and proteasomal degradation of the receptor
Myat Lin Oo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
FTY720 treatment of kidney transplant patients: A differential effect on B cells, naive T cells, memory T cells and NK cells
Leonard M. B. Vaessen et al.
TRANSPLANT IMMUNOLOGY (2006)
Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability
T Sanchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sphingosine-1-phosphate receptors and the development of the vascular system
ML Allende et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Share Paper
